Bio-Rad Laboratories, Inc. logo
Bio-Rad Laboratories, Inc. (BIO)
Compare

BIO Financials

SEC Filings

BIO Quarterly Income Statement (USD)

Quarterly ReportTTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
09/30/2024
06/30/2024
1.343B309.400M345.200M343.400M345.300M306.000M341.912M355.903M355.119M
2.590B592.100M693.200M653.000M651.600M585.400M667.475M649.729M638.476M
Cost of Goods Sold
1.247B282.700M348.000M309.600M306.300M279.400M325.563M293.826M282.757M
52.3%52.3%49.8%52.6%53.0%52.3%51.2%54.8%55.6%
Total Operating Expenses
1.104B275.300M282.300M278.100M268.200M282.300M283.582M291.437M253.623M
260.400M62.900M65.700M71.300M60.500M73.500M79.624M90.997M59.304M
843.500M212.400M216.600M206.800M207.700M208.800M204.000M200.440M196.119M
239.500M34.100M61.900M66.400M77.100M23.700M58.330M64.466M101.496M
5.8%5.8%8.9%10.2%11.8%4.0%8.7%9.9%15.9%
222.300M-689.800M929.200M-431.100M414.000M83.400M-908.900M861.620M-2.786B
Interest Income
59.400M31.000M13.700M14.700M36.200M15.900M15.500M16.600M
49.300M12.300M12.100M12.300M12.600M12.000M12.185M12.174M12.264M
Other Income/Expense
-17.200M-723.900M867.300M-497.500M336.900M59.700M-967.230M797.154M-2.888B
168.800M-527.100M720.000M-341.900M317.800M64.000M-715.800M653.172M-2.165B
53.500M-162.700M209.200M-89.200M96.200M19.400M-193.100M208.448M-620.795M
-89.0%-89.0%103.9%-52.4%48.8%10.9%-107.2%100.5%-339.2%
34.600M-677.500M114.300M120.600M477.200M133.500M-847.400M922.894M-2.727B
EBITDA Margin
-114.4%-114.4%16.5%18.5%73.2%22.8%-127.0%142.0%-427.2%
157.200M0.0052.400M54.200M50.600M38.100M49.300M49.100M46.600M
EPS Basic
6.11-19.5526.69-12.7011.672.29-25.5723.37-76.26
6.07-19.5526.65-12.7011.672.29-25.5723.34-76.26
Shares Outstanding
26.958M26.958M26.976M26.923M27.226M27.941M27.997M27.949M28.395M
Diluted Shares Outstanding
26.958M26.958M27.012M26.923M27.228M27.955M27.997M27.985M28.395M

BIO Annual Income Statement (USD)

Annual Report
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
1.344B1.379B1.427B1.567B1.638B1.438B1.257B1.224B
2.583B2.567B2.671B2.802B2.923B2.546B2.312B2.290B
Cost of Goods Sold
1.240B1.188B1.244B1.235B1.284B1.108B1.055B1.066B
52.0%53.7%53.4%55.9%56.1%56.5%54.4%53.5%
Total Operating Expenses
1.077B1.110B1.089B1.085B1.138B1.017B1.027B1.032B
256.900M295.900M247.427M256.889M260.638M217.763M202.710M199.196M
819.900M814.000M841.700M827.825M877.122M798.798M824.625M833.294M
270.500M269.000M337.796M482.616M500.336M421.326M229.661M-108.641M
10.5%10.5%12.6%17.2%17.1%16.6%9.9%-4.7%
995.500M-2.342B-850.104M-4.704B5.449B4.918B2.261B507.359M
Interest Income
95.500M82.000M100.900M58.000M18.900M18.200M30.500M26.600M
49.000M48.900M49.439M38.114M1.551M21.861M23.416M23.962M
Other Income/Expense
725.000M-2.611B-1.188B-5.187B4.949B4.497B2.031B319.387M
759.900M-1.844B-637.324M-3.628B4.254B3.814B1.759B360.996M
235.600M-498.300M-212.780M-1.077B1.195B1.104B502.406M146.363M
29.4%-71.9%-23.9%-129.5%145.6%149.8%76.1%15.8%
475.900M-2.142B-654.800M-4.489B5.588B5.078B2.459B674.721M
EBITDA Margin
18.4%-83.5%-24.5%-160.2%191.2%199.5%106.4%29.5%
205.400M151.600M145.900M177.200M137.600M138.600M174.500M138.100M
EPS Basic
27.87-65.36-21.82-121.79142.61127.8658.9312.10
27.87-65.36-21.82-121.79140.83126.2058.2711.94
Shares Outstanding
27.263M28.214M29.209M29.785M29.831M29.768M29.843M29.836M
Diluted Shares Outstanding
27.281M28.214M29.209M29.785M30.208M30.160M30.184M30.228M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Hercules, CA
7,700 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Norman D. Schwartz